Study: Paxlovid cuts hospitalization, death only in at-risk COVID patients with weak immune systems | CIDRAP
Discussion
nostr:npub1xxdjunlfj2u33un56dmsdat3zs3hp2hdcvf6a9myqmcq30u2rlaqgrhnjg Yet may also lower the long covid risk, is that an end piint assessed?